Publications 2025

Clinical Effectiveness Research Group – list of publications 2025

The Enemy. 

Bretthauer M. Ann Intern Med. 2025 Dec 23. doi: 10.7326/ANNALS-25-04873. Online ahead of print. PMID: 41429025 No abstract available.

Level 2 Impact Factor 15.4

The Legal and Ethical Framework for Artificial Intelligence in Gastrointestinal Endoscopy: A World Endoscopy Organization International Consensus Statement.

Ahmad OF, Mori Y, Bretthauer M, Dourado DA, Hassan C, Bisschops R, Bhandari P, Byrne MF, Dekker E, Mahadevan U, May FP, Messmann H, Misawa M, Ogata H, Saito Y, Silverman AL, Wang P, Yano T, Aabakken L, Berzin TM. Ann Intern Med. 2025 Dec 9. doi: 10.7326/ANNALS-25-03415. Online ahead of print.PMID: 41359967

Level 2 Impact Factor 15.4

Addressing Colonoscopy Burden Due to Artificial Intelligence Devices for Polyp Detection.

Mori Y, Wang P, Kamba S, Liu L, Siersema PD, Hassan C; Co-AID Study Group. Gastroenterology. 2026 Feb;170(2):398-400. doi: 10.1053/j.gastro.2025.08.019. Epub 2025 Dec 2.PMID: 41329113 Free article. No abstract available.

Level 2 Impact Factor 25.9

Faecal microbiota transplantation for primary Clostridioides difficile infection.

Bø S, Wiig H, Juul FE, Garborg KK, Johnsen PH, Bretthauer M. Tidsskr Nor Laegeforen. 2025 Nov 19;145(14). doi: 10.4045/tidsskr.25.0276. Print 2025 Nov 25.PMID: 41292332 Free article. English, Norwegian.

Level 1

Avlæring og ferdighetsreduksjon ved bruk av kunstig intelligens.

Gjersvik P, Bretthauer M. Tidsskr Nor Laegeforen. 2025 Nov 3;145(13). doi: 10.4045/tidsskr.25.0565. Print 2025 Nov 4.PMID: 41196202 Free article. Norwegian. No abstract available.

Level 1

Large language model for interpreting the Paris classification of colorectal polyps.

Massimi D, Carlini L, Mori Y, Di Stefano L, Antonelli G, Rizkala T, Spadaccini M, de Sire R, Alfarone L, Lena C, D'Aprano A, Parasa S, Bisschops R, von Renteln D, O'Reilly SM, Savevski V, Sharma P, Rex DK, Bretthauer M, Demomi E, Hassan C, Repici A. Endosc Int Open. 2025 Oct 9;13:a27030209. doi: 10.1055/a-2703-0209. eCollection 2025.PMID: 41079216 Free PMC article.

Level 1 Impact Factor 2.3

Environmental impact of computer-aided diagnosis in colonoscopy: a carbon footprint assessment of a prospective study cohort.

Olabintan O, Halvorsen N, Baddeley R, Kudo SE, Barua I, Misawa M, Mori K, Hunt C, Nilsen JA, Frigstad SO, East JE, Rastogi A, Hassan C, Kalager M, Løberg M, Haji A, Holme Ø, Bretthauer M, Hayee B, Mori Y, Gulati S. Endoscopy. 2025 Nov 19. doi: 10.1055/a-2717-8365. Online ahead of print.PMID: 41056995 Free article. Clinical Trial.

Level 2 Impact Factor 12.8

[What is confirmed in colorectal cancer screening?]

Full text in German.

Bretthauer M. Inn Med (Heidelb). 2025 Dec;66(12):1251-1257. doi: 10.1007/s00108-025-01983-5. Epub 2025 Sep 11.PMID: 40952509 Free PMC article. Review. German.

Level 1 Impact Factor 0.6

Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative - Update 2025.

Areia M, Esposito G, Leclercq P, Romańczyk M, Zessner-Spitzenberg J, Delgado Guillena PG, Monged A, Honrubia López R, Uchima H, Ruiz Ballesteros EJ, Panarese A, Reis de Oliveira LA, Afify S, Bisschops R, Ferlitsch M; External Voting Panel. Endoscopy. 2025 Nov;57(11):1268-1297. doi: 10.1055/a-2674-4912. Epub 2025 Sep 11.PMID: 40934951 Free article.

Level 2 Impact Factor 12.8

Å forberede medisinstudenter på usikkerhet.

Helsingen LM, Bretthauer M, Lie AK, Lundin KEA, Løberg M.Tidsskr Nor Laegeforen. 2025 Aug 21;145(10). doi: 10.4045/tidsskr.25.0480. Print 2025 Sep 9.PMID: 40923171 Free article. Norwegian. No abstract available.

Level 1

Safety of artificial intelligence-assisted optical diagnosis for leaving colorectal polyps in situ during colonoscopy (PRACTICE): a non-inferiority, randomised controlled trial.

Antonelli G, Desideri F, Scarozza P, Andrisani G, Zerboni G, Furnari M, Bevilacqua N, Cossignani M, Di Fonzo M, Cereatti F, Navazzotti G, Antenucci C, Di Matteo FM, Bevivino G, Caruso A, Spadaccini M, Schiavone S, Grossi C, Rizkala T, Comberlato M, Bretthauer M, Sharma P, Von Renteln D, Rex DK, Correale L, Repici A, Mori Y, Iacopini F, Hassan C. Lancet Gastroenterol Hepatol. 2025 Oct;10(10):915-923. doi: 10.1016/S2468-1253(25)00140-2.PMID: 40914178 Clinical Trial.

Level 2 Impact Factor 30.9

Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study.

Budzyń K, Romańczyk M, Kitala D, Kołodziej P, Bugajski M, Adami HO, Blom J, Buszkiewicz M, Halvorsen N, Hassan C, Romańczyk T, Holme Ø, Jarus K, Fielding S, Kunar M, Pellise M, Pilonis N, Kamiński MF, Kalager M, Bretthauer M, Mori Y. Lancet Gastroenterol Hepatol. 2025 Oct;10(10):896-903. doi: 10.1016/S2468-1253(25)00133-5. Epub 2025 Aug 12.PMID: 40816301

Level 2 Impact Factor 30.9

Adenoma detection and subsequent colorectal cancer risk: is the race really over?

Frazzoni L, Antonelli G, Pilonis ND, Wisse PHA, Facciorusso A, Spaander MCW, Dinis Ribeiro M, Barbara G, Orlandini F, Di Marco M, De Padova A, Spada C, Dekker E, Bretthauer M, Kaminski MF, Hassan C, Fuccio L.Gut. 2025 Jun 27:gutjnl-2025-335225. doi: 10.1136/gutjnl-2025-335225. Online ahead of print.PMID: 40579120 No abstract available.

Level 2 Impact Factor 26.2

Trinnvis kileklyngerandomisering.

Bretthauer M, Gjersvik P.Tidsskr Nor Laegeforen. 2025 Jun 11;145(8). doi: 10.4045/tidsskr.25.0094. Print 2025 Jun 24.PMID: 40575822 Free article. Norwegian. No abstract available.

Level 1

Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection : A Randomized Controlled Trial.

Juul FE, Bretthauer M, Johnsen PH, Samy F, Tonby K, Berdal JE, Hoff DAL, Ofstad EH, Abraham A, Seip B, Wiig H, Rognstad ØB, Glad IF, Valeur J, Nissen-Lie AE, Ness-Jensen E, Lund KMA, Skjevling LK, Hanevik K, Skudal H, Melsom EJ, Boyar R, Cooper TJ, Ranheim TE, Riise EM, Adami HO, Kalager M, Løberg M, Garborg KK.Ann Intern Med. 2025 Jul;178(7):940-947. doi: 10.7326/ANNALS-24-03285. Epub 2025 Jun 17.PMID: 40523286 Clinical Trial.

Level 2 Impact Factor 15.4

Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy.

Witte M, Oltmanns C, Tauwaldt J, Schmaus H, Mischke J, Grabert G, Bretthauer M, Roesner LM, Werfel T, Deterding K, Maasoumy B, Wedemeyer H, Kacprowski T, Kraft ARM, Cornberg M. Clin Mol Hepatol. 2025 Oct;31(4):1269-1284. doi: 10.3350/cmh.2025.0292. Epub 2025 Jun 4.PMID: 40462644 Free PMC article.

Level 1 Impact Factor 16.9

Large language models for detecting colorectal polyps in endoscopic images.

Carlini L, Massimi D, Mori Y, Antonelli G, Rizkala T, Spadaccini M, Lena C, Parasa S, Bisschops R, von Renteln D, O'Reilly S, Sharma P, Rex DK, Bretthauer M, Repici A, De Momi E, Hassan C. Gut. 2025 May 24:gutjnl-2025-335091. doi: 10.1136/gutjnl-2025-335091. Online ahead of print.PMID: 40360230 No abstract available.

Level 2 Impact Factor 26.2

Artificial intelligence and colorectal neoplasia detection performances in patients with positive fecal immunochemical test: Meta-analysis and systematic review.

Spadaccini M, Hassan C, Mori Y, Halvorsen N, Gimeno-García AZ, Nakashima H, Facciorusso A, Patel HK, Antonelli G, Khalaf K, Rizkala T, Ramai D, Rondonotti E, Kamba S, Maselli R, Correale L, Bretthauer M, Bhandari P, Sharma P, Rex DK, Repici A; CADe group. Dig Endosc. 2025 Aug;37(8):815-823. doi: 10.1111/den.15034. Epub 2025 May 6.PMID: 40328639

Level 1 Impact Factor 4.7

Effect of colonoscopy screening on risks of colorectal cancer and related death: instrumental variable estimation of per-protocol effects.

Shi J, Løberg M, Kalager M, Wieszczy P, Pilonis ND, Adami HO, Kaminski MF, Bretthauer M, Hernán MA; The NordICC Study Group. Eur J Epidemiol. 2025 Apr;40(4):419-425. doi: 10.1007/s10654-025-01209-w. Epub 2025 Apr 25.PMID: 40278966 Clinical Trial.

Level 2 Impact Factor 5.9

Screening for many types of cancer with a single blood sample - too good to be true?

Weinberg D, Bretthauer M.Tidsskr Nor Laegeforen. 2025 Apr 21;145(5). doi: 10.4045/tidsskr.25.0077. Print 2025 Apr 22.PMID: 40272130 Free article. English, Norwegian. No abstract available.

Level 1

Benefits, burden, and harms of computer aided polyp detection with artificial intelligence in colorectal cancer screening: microsimulation modelling study.

Halvorsen N, Hassan C, Correale L, Pilonis N, Helsingen LM, Spadaccini M, Repici A, Foroutan F, Olav Vandvik P, Sultan S, Løberg M, Kalager M, Mori Y, Bretthauer M. BMJ Med. 2025 Mar 27;4(1):e001446. doi: 10.1136/bmjmed-2025-001446. eCollection 2025 Jan.PMID: 40166696 Free PMC article.

Level 1 Impact Factor 10.0

Gastroenterology/Hepatology: What You May Have Missed in 2024.

Cintosun A, Jamal I, Samnani S, Song YN, Bretthauer M. Ann Intern Med. 2025 May;178(5_Supplement):S39-S53. doi: 10.7326/ANNALS-25-00959. Epub 2025 Apr 1.PMID: 40163879 Review.

Level 2 Impact Factor 15.4

First head-to-head trial of colonoscopy versus faecal testing for colorectal cancer screening.

Bretthauer M, Kalager M. Lancet. 2025 Apr 12;405(10486):1204-1206. doi: 10.1016/S0140-6736(25)00288-0. Epub 2025 Mar 27.PMID: 40158522 No abstract available.

Level 2 Impact Factor 88.5

Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Bretthauer M, Ahmed J, Antonelli G, Beaumont H, Beg S, Benson A, Bisschops R, De Cristofaro E, Gibbons E, Häfner M, Karsenti D, Laquière A, Loly JP, O'Reilly SM, Pellisé M, Grubelic Ravic K, Triantafyllou K, Tziatzios G, Valente R, Walter BM, Wiesand M, Lorenzo-Zúñiga V, Gralnek IM. Endoscopy. 2025 Jun;57(6):667-673. doi: 10.1055/a-2543-0370. Epub 2025 Mar 27.PMID: 40148135 Free article.

Level 2 Impact Factor 12.8

Temporal trends in characteristics and management of inflammatory bowel disease.

Young JC, Helsingen LM, Refsum E, Högdén A, Perrin V, Løberg M, Gantzel RH, Bretthauer M, Berglund A, Holme Ø, Jodal HC, Grimstad T, Brackmann SA, Ye W, Adami HO, Larsen L, Hernan MA, Jess T, Blom J, Kalager M. Scand J Gastroenterol. 2025 May;60(5):421-429. doi: 10.1080/00365521.2025.2478166. Epub 2025 Mar 24. PMID: 40126153 Free article. Review.

Level 1 Impact Factor 1.7

Correction: Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study.

Halvorsen N, Barua I, Kudo SE, Gulati S, Misawa M, Mori K, Hayee B, Olabintan O, Nilsen JA, Frigstad SO, East JE, Rastogi A, Hassan C, Kalager M, Løberg M, Holme Ø, Haji A, Bretthauer M, Mori Y. Endoscopy. 2025 Jun;57(6):C6. doi: 10.1055/a-2548-0262. Epub 2025 Feb 28.PMID: 40020708 No abstract available.

Level 2 Impact Factor 12.8

Screening for Helicobacter pylori to Prevent Gastric Cancer.

Kumar S, Bretthauer M. JAMA. 2025 Mar 4;333(9):812-813. doi: 10.1001/jama.2024.26377.PMID: 39908039 No abstract available.

Level 2 Impact Factor 55.0

Adenoma Detection Rates by Physicians and Subsequent Colorectal Cancer Risk.

Pilonis ND, Spychalski P, Kalager M, Løberg M, Wieszczy P, Didkowska J, Wojciechowska U, Kobiela J, Regula J, Rösch T, Bretthauer M, Kaminski MF.JAMA. 2025 Feb 4;333(5):400-407. doi: 10.1001/jama.2024.22975.PMID: 39680377 Free PMC article.

Level 2 Impact Factor 55.0

Aneuploidy patterns in colorectal cancer.

Zaalberg IC, Ketelaars SLC, Jodal HC, Løberg M, Kalager M, Meijer GA, Carvalho B, Lens SMA.Cell Rep. 2026 Jan 27;45(1):116721. doi: 10.1016/j.celrep.2025.116721. Epub 2025 Dec 17.PMID: 41411129 Free article. Review.

Level 2 Impact Factor 6.9

Colorectal ESD in a nordic community hospital: learning curves and clinical outcomes.

Nilsen JA, Juul FE, Egeland A, Tandberg P, Norvard E, Lund-Iversen T, Schultz JK, Kalager M, Frigstad SO.Scand J Gastroenterol. 2025 Nov;60(11):1043-1052. doi: 10.1080/00365521.2025.2553279. Epub 2025 Aug 30.PMID: 40884425 Free article.

Level 1 Impact Factor 1.7

When Would You Screen This 39-Year-Old Woman for Breast Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.

Kanjee Z, Wong JB, Kalager M, Burns RB.Ann Intern Med. 2025 Oct;178(10):1478-1486. doi: 10.7326/ -25-03548. Epub 2025 Oct 14.PMID: 41082724

Level 2 Impact Factor 15.4

Temporal trends in surgical treatment of inflammatory bowel disease following introduction of biological drugs in Norway and Sweden.

Högdén A, Perrin V, Adami HO, Kalager M, Jess T, Ye W, Young J, Helsingen LM, Refsum E, Blom J. BMJ Open Gastroenterol. 2025 Jun 19;12(1):e001828. doi: 10.1136/bmjgast-2025-001828.PMID: 40541271 Free PMC article.

Level 1 Impact Factor 2.9

Fitting a progressive 3-state colorectal cancer model to interval-censored surveillance data under outcome-dependent sampling using a weighted likelihood approach.

Akwiwu EU, Klausch T, Jodal HC, Carvalho B, Løberg M, Kalager M, Berkhof J, Coupé VMH. Am J Epidemiol. 2025 Jun 3;194(6):1764-1775. doi: 10.1093/aje/kwae307.PMID: 39214647

Level 2 Impact Factor 4.8

Incremental value of mucosal exposure device to computer-aided detection in colonoscopy: A meta-analysis and trial sequential analysis.

Brigida M, Spadaccini M, Maida M, Almuhaidb A, Gadour E, Crinò SF, Dell'Anna G, Donatelli G, Andrisani G, Stasi E, Dell'Anna A, Hassan C, Mori Y, Facciorusso A. Dig Liver Dis. 2026 Feb;58(2):206-211. doi: 10.1016/j.dld.2025.12.010. Epub 2025 Dec 29.PMID: 41469249 Free article. Review.

Level 1 Impact Factor 3.8

Correction: Curriculum for safe and effective use of artificial intelligence in endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.

Mori Y, Kopylov U, Sinonquel P, Ebigbo A, Dekker E, De Groof AJ, Ahmad OF, Kader R, Saftoiu A, Schoon E, Mascagni P, Bhandari P, Hann A, Antonelli G, Iacucci M, Pech O, Dray X, Spadaccini M, Campion JR, Hassan C, Messmann H, Bisschops R, Fuccio L, Facciorusso A, Tham T. Endoscopy. 2026 Feb;58(2):C3. doi: 10.1055/a-2765-1088. Epub 2025 Dec 5.PMID: 41349574 No abstract available.

Level 2 Impact Factor 12.8

Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy - Authors' reply.

Budzyń K, Romańczyk M, Mori Y.Lancet Gastroenterol Hepatol. 2025 Dec;10(12):1062. doi: 10.1016/S2468-1253(25)00324-3.PMID: 41205617 No abstract available.

Level 2 Impact Factor 30.9

Null Effect of Computer-Aided Detection in Colonoscopy: News or Illusion?

Hassan C, Mori Y, Rizkala T. Dig Endosc. 2025 Dec;37(12):1351-1352. doi: 10.1111/den.70023. Epub 2025 Sep 3.PMID: 40898811 No abstract available.

Level 1 Impact Factor 4.7

Bowel preparation quality and computer-aided detection of adenomas during colonoscopy.

Muccichini E, Rondonotti E, Spadaccini M, Segatta F, Savino A, Paggi S, Bina N, Brandaleone L, Di Martino A, Hassan C, Mori Y, Fuccio L, Repici A, Radaelli F. Dig Liver Dis. 2025 Nov;57(11):2174-2179. doi: 10.1016/j.dld.2025.08.072. Epub 2025 Sep 8. PMID: 40925780

Level 1 Impact Factor 3.8

World Endoscopy Organization's Response to the World Health Organization's Global Initiative on Artificial Intelligence for Health.

Coelho-Prabhu N, Bhat P, Kalapala R, Mushtaq J, Tajiri H, Mori Y.Dig Endosc. 2025 Nov;37(11):1143-1147. doi: 10.1111/den.70011. Epub 2025 Aug 4.PMID: 40759486 Review.

Level 1 Impact Factor 4.7

Understanding the Role of Computer-Aided Diagnosis in Colonoscopy.

Halvorsen N, Mori Y.Dig Endosc. 2025 Nov;37(11):1227-1228. doi: 10.1111/den.70007. Epub 2025 Jul 25.PMID: 40709574 No abstract available.

Level 1 Impact Factor 4.7

Underwater versus traction-assisted endoscopic submucosal dissection for colorectal lesions: a network meta-analysis of randomized controlled trials.

de Sire R, Spadaccini M, De Deo D, Massimi D, Alfarone L, Capogreco A, Facciorusso A, Andrisani G, Sferrazza S, Jacques J, Alkandari A, Bhandari P, Mori Y, Hassan C, Maselli R, Repici A .Gastrointest Endosc. 2025 Oct 10:S0016-5107(25)02074-7. doi: 10.1016/j.gie.2025.09.054. Online ahead of print.PMID: 41076024 Review.

Level 1 Impact Factor 7.5

Same evidence but different recommendations - Dilemma in computer-aided detection in colonoscopy.

Hassan C, Mori Y. Endoscopy. 2025 Oct;57(10):1180-1181. doi: 10.1055/a-2651-7353. Epub 2025 Sep 24.PMID: 40992369 No abstract available.

Level 2 Impact Factor 12.8

Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements.

Mori Y, Ishihara R, Ogata H, Kutsumi H, Saito Y, Sumiyama K, Sekiguchi M, Tajiri H, Fujishiro M, Matsuda K, Yano T, Aoki R, Ishiyama M, Imagawa A, Omae M, Oda Y, Kato M, Sakamoto T, Sasabe M, Shiotani A, Suzuki S, Tamai N, Hikichi T, Hirasawa T, Makiguchi M, Misawa M, Yabuuchi Y, Yamaguchi D, Yamada M, Igarashi Y, Tanaka S.Dig Endosc. 2025 Oct;37(10):1116-1122. doi: 10.1111/den.15075. Epub 2025 Jun 30.PMID: 40586266

Level 1 Impact Factor 4.7

Colon Cancer Screening, Surveillance, and Treatment: Novel Artificial Intelligence Driving Strategies in the Management of Colon Lesions.

Hassan C, Bisschops R, Sharma P, Mori Y. Gastroenterology. 2025 Aug;169(3):444-455. doi: 10.1053/j.gastro.2025.02.021. Epub 2025 Mar 5.PMID: 40054749 Review.

Level 2 Impact Factor 25.9

Computer-aided diagnosis of colorectal polyps: assisted or autonomous?

Mori Y, Hassan C. Clin Endosc. 2025 Jul;58(4):514-517. doi: 10.5946/ce.2024.338. Epub 2025 May 22.PMID: 40400307 Free PMC article. Review.

Level 1 Impact Factor 2.3

Variability in computer-aided detection effect on adenoma detection rate in randomized controlled trials: A meta-regression analysis.

Spadaccini M, Hassan C, Mori Y, Massimi D, Correale L, Facciorusso A, Patel HK, Rizkala T, Khalaf K, Ramai D, Rondonotti E, Maselli R, Rex DK, Bhandari P, Sharma P, Repici A; CADe Study group. Dig Liver Dis. 2025 Jun;57(6):1141-1148. doi: 10.1016/j.dld.2025.01.192. Epub 2025 Feb 8.PMID: 39924430

Level 1 Impact Factor 3.8

Exploring ChatGPT effectiveness in addressing direct patient queries on colorectal cancer screening.

Maida M, Mori Y, Fuccio L, Sferrazza S, Vitello A, Facciorusso A, Hassan C.Endosc Int Open. 2025 May 12;13:a25689416. doi: 10.1055/a-2568-9416. eCollection 2025.PMID: 40376022 Free PMC article.

Level 1 Impact Factor 2.3

Detection of large flat colorectal lesions by artificial intelligence: a persistent weakness and blind spot.

Rex DK, Guardiola JJ, von Renteln D, Mori Y, Sharma P, Hassan C. Gut. 2025 May 7;74(6):881-883. doi: 10.1136/gutjnl-2024-334456.PMID: 39773470 No abstract available.

Level 2 Impact Factor 26.2

Correction: The Gastroscopy RAte of Cleanliness Evaluation (GRACE) Scale: an international reliability and validation study.

Esposito G, Dilaghi E, Costa-Santos C, Ligato I, Annibale B, Dinis-Ribeiro M, Areia M; GRACE Investigators. Endoscopy. 2025 Apr;57(4):C2. doi: 10.1055/a-2545-0228. Epub 2025 Feb 26.PMID: 40010401 No abstract available.

Level 2 Impact Factor 12.8

Combination of white-light imaging-based and narrow-band imaging-based artificial intelligence models during colonoscopy in patients with ulcerative colitis.

Kuroki T, Maeda Y, Kudo SE, Ogata N, Takabayashi K, Takenaka K, Kawashima J, Kawabata Y, Iwasaki S, Shiina O, Morita Y, Kouyama Y, Sakurai T, Ogawa Y, Baba T, Mori Y, Iacucci M, Ogata H, Ohtsuka K, Misawa M. J Crohns Colitis. 2025 Jan 11;19(1):jjaf014. doi: 10.1093/ecco-jcc/jjaf014.PMID: 39888722

Level 2 Impact Factor 8.7

Artificial Intelligence-assisted Video Colonoscopy for Disease Monitoring of Ulcerative Colitis: A Prospective Study.

Ogata N, Maeda Y, Misawa M, Takenaka K, Takabayashi K, Iacucci M, Kuroki T, Takishima K, Sasabe K, Niimura Y, Kawashima J, Ogawa Y, Ichimasa K, Nakamura H, Matsudaira S, Sasanuma S, Hayashi T, Wakamura K, Miyachi H, Baba T, Mori Y, Ohtsuka K, Ogata H, Kudo SE.J Crohns Colitis. 2025 Jan 11;19(1):jjae080. doi: 10.1093/ecco-jcc/jjae080.PMID: 38828734 Free PMC article.

Level 2 Impact Factor 8.7

Clostridioides difficile-infeksjon.

Skåland MI, Tonby K, Ingebretsen A, Gammelsrud KW, Garborg KK, Juul FE.Tidsskr Nor Laegeforen. 2025 Jun 2;145(7). doi: 10.4045/tidsskr.24.0233. Print 2025 Jun 3.PMID: 40474631 Free article. Review. Norwegian.

Level 1

Bakteriell overdiagnostikk i tynntarm.

Bekkelund M, Juul FE, Sandstad O, Valeur J.Tidsskr Nor Laegeforen. 2025 Jan 24;145(2). doi: 10.4045/tidsskr.24.0655. Print 2025 Feb 11.PMID: 39932094 Free article. Norwegian. No abstract available.

Level 1

Underwater endoscopic submucosal dissection of a 20-cm-long circular rectosigmoid polyp.

Nilsen JA, Egeland A, Tandberg P, Darre-Næss O, Norvard ER, Hvattum S. Endoscopy. 2025 Dec;57(S 01):E606-E607. doi: 10.1055/a-2610-2567. Epub 2025 Jun 18.PMID: 40532913 Free PMC article. No abstract available.

Level 2 Impact Factor 12.8

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models.

Classon J, Stenudd M, Zamboni M, Alkass K, Eriksson CJ, Pedersen L, Schörling A, Thoss A, Bergh A, Wikström P, Adami HO, Sørensen HT, Druid H, Frisén J. Mol Oncol. 2025 Nov;19(11):3035-3059. doi: 10.1002/1878-0261.70073. Epub 2025 Jun 10.PMID: 40493023 Free PMC article.

Level 2 Impact Factor 4.5

Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.

Holmberg L, Garmo H, Andersson SO, Andrén O, Johansson E, Taari K, Häggman M, Nordling S, Adami HO, Bill-Axelson A. Eur Urol. 2025 Dec;88(6):554-558. doi: 10.1016/j.eururo.2025.07.001. Epub 2025 Jul 30. PMID: 40744802 Clinical Trial.

Level 2 Impact Factor 25.2

Reply to Yafei Wang, Qianting Lu, and Xin Zhao's Letter to the Editor re: Lars Holmberg, Hans Garmo, Sven-Olov Andersson, et al. Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.001.

Holmberg L, Adami HO, Bill-Axelson A. Eur Urol. 2025 Oct 6:S0302-2838(25)04701-3. doi: 10.1016/j.eururo.2025.09.4151. Online ahead of print.PMID: 41058369 Free article. No abstract available.

Level 2 Impact Factor 25.2

Association of Pre-Diagnostic Clonal Hematopoiesis of Indeterminate Potential With Prognosis Among Patients With Cancer.

Liu X, Adami HO, Wästerlid T, Xue H, Feychting M, Smedby KE, Fang F, Liu Q. Am J Hematol. 2025 Nov;100(11):1993-2003. doi: 10.1002/ajh.70028. Epub 2025 Aug 11.PMID: 40787700

Level 1 Impact Factor 10.3

Dietary non-enzymatic antioxidant capacity and risk of breast cancer: the Swedish National March Cohort.

Mariosa D, Ponzano M, Grotta A, Lagerros YT, Hantikainen E, Adami HO, Serafini M, Bellocco R, Ye W. BMC Cancer. 2025 Aug 13;25(1):1310. doi: 10.1186/s12885-025-14658-z.PMID: 40797303 Free PMC article.

Level 1 Impact Factor 3.4

Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North America.

Naudin S, Wang M, Dimou N, Ebrahimi E, Genkinger J, Adami HO, Albanes D, Babic A, Barnett M, Bogumil D, Cai H, Chen C, Eliassen AH, Freudenheim JL, Gierach G, Giovannucci EL, Gunter MJ, Håkansson N, Hirabayashi M, Hou T, Huang BZ, Huang WY, Jayasekara H, Jones ME, Katzke VA, Koh WP, Lacey JV, Lagerros YT, Larsson SC, Liao LM, Lo K, Loftfield E, MacInnis RJ, Männistö S, McCullough ML, Miller A, Milne RL, Moore SC, Mucci LA, Neuhouser ML, Patel AV, Platz EA, Prizment A, Robien K, Rohan TE, Sacerdote C, Sandin S, Sawada N, Schoemaker M, Shu XO, Sinha R, Snetselaar L, Stampfer MJ, Stolzenberg-Solomon R, Thomson CA, Tjønneland A, Um CY, van den Brandt PA, Visvanathan K, Wang SS, Wang R, Weiderpass E, Weinstein SJ, White E, Willett W, Woslk A, Wolpin BM, Yaun SS, Yuan C, Yuan JM, Zheng W, Brennan P, Smith-Warner SA, Ferrari P. PLoS Med. 2025 May 20;22(5):e1004590. doi: 10.1371/journal.pmed.1004590. eCollection 2025 May.PMID: 40392909 Free PMC article.

Level 2 Impact Factor 9.9

A genome-wide association study integrated with single-cell and bulk profiles uncovers susceptibility genes for nasopharyngeal carcinoma involved in tumorigenesis via regulation of T cells.

Wang TM, Zhang WL, Xie JR, He YQ, Tang M, Xue WQ, Yang DW, Deng CM, Diao H, Mai ZM, Xiao RW, Liao Y, Li DH, Wu YX, Jiang CT, Zhang JB, Chen XY, Du Y, Tang CL, Jia WH, Zhou T, Li XZ, Zhang PF, Zheng XH, Zhang SD, Hu YZ, Cai Y, Zheng Y, Zhang Z, Jin G, Chen W, Mai HQ, Sun Y, Hu Z, Liu J, Guan XY, Bai F, Bei J, Ma J, Zeng M, Lung ML, Adami HO, Ye W, Lam TH, Shen H, Jia WH. Genome Biol. 2025 Jul 7;26(1):195. doi: 10.1186/s13059-025-03657-9.PMID: 40624598 Free PMC article.

Level 2 Impact Factor 9.4

Interstitial Lung Disease and Risk of Lung Cancer.

Xu H, Yin L, Bian W, Kang M, Adami HO, Ye W. JAMA Netw Open. 2025 Jul 1;8(7):e2519630. doi: 10.1001/jamanetworkopen.2025.19630.PMID: 40632533 Free PMC article.

Level 1 Impact Factor 9.7

Mortality in polymyalgia rheumatica: a 38-year prospective population-based cohort study from Southern Norway.

Tengesdal S, Molberg Ø, Holme Ø, Gran JT, Myklebust G. Arthritis Res Ther. 2025 Jul 21;27(1):154. doi: 10.1186/s13075-025-03613-9.PMID: 40691638 Free PMC article.

Level 2 Impact Factor 4.6

Computer aided detection and diagnosis of polyps in adult patients undergoing colonoscopy: a living clinical practice guideline.

Foroutan F, Vandvik PO, Helsingen LM, Kalager M, Rutter M, Selby K, Pilonis ND, Anderson JC, McKinnon A, Fuchs JM, Quinlan C, Buskermolen M, Senore C, Wang P, Sung JJY, Haug U, Bjerkelund S, Triantafyllou K, Shung DL, Halvorsen N, McGinn T, Hafver TL, Reinthaler V, Guyatt G, Agoritsas T, Sultan S. BMJ. 2025 Mar 27;388:e082656. doi: 10.1136/bmj-2024-082656.PMID: 40147837

Level 2 Impact Factor 43.0

Exploring the clinical value of concept-based AI explanations in gastrointestinal disease detection.

Storås AM, Dreyer M, Pahde F, Lapuschkin S, Samek W, Halvorsen P, de Lange T, Mori Y, Hann A, Berzin TM, Parasa S, Riegler MA. Sci Rep. 2025 Aug 7;15(1):28860. doi: 10.1038/s41598-025-14408-y.PMID: 40775463 Free PMC article.

Impact Factor 3.9

Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.

Brantley KD, Jones ME, Tamimi RM, Rosner BA, Kraft P, Nichols HB, O'Brien KM, Adami HO, Aizpurua A, Berrington de González A, Blot WJ, Braaten T, Chen Y, DeHart JC, Dossus L, Elias S, Fortner RT, Garcia-Closas M, Gram IT, Håkansson N, Hankinson SE, Kitahara CM, Koh WP, Linet MS, MacInnis RJ, Masala G, Mellemkjær L, Milne RL, Muller DC, Park HL, Ruddy KJ, Sandin S, Shu XO, Tin Tin S, Truong T, Vachon CM, Vatten LJ, Visvanathan K, Weiderpass E, Willett W, Wolk A, Yuan JM, Zheng W, Sandler DP, Schoemaker MJ, Swerdlow AJ, Eliassen AH. Breast Cancer Res. 2025 May 1;27(1):67. doi: 10.1186/s13058-025-02031-8.PMID: 40312753 Free PMC article.

Level 2 Impact Factor 5.6

Premenopausal Breast Cancer Collaborative Group. Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women.

Schoemaker MJ, Ellington T, Nichols HB, Wright LB, Jones ME, O'Brien KM, Weinberg CR, Adami HO, Baglietto L, Bertrand KA, Chen Y, Clague DeHart J, Eliassen AH, Giles GG, Houghton SC, Kirsh VA, Milne RL, Palmer JR, Park HL, Rohan TE, Severi G, Shu XO, Tamimi RM, Vatten LJ, Weiderpass E, Willett WC, Zeleniuch-Jacquotte A, Zheng W, Sandler DP, Swerdlow AJ; Breast Cancer Res. 2025;27(1):55. PMID: 40234955 PMCID: PMC12001638 DOI: 10.1186/s13058-025-01995-x

Level 2 Impact Factor 5.6

Different behavior of electrosurgical currents between air and saline immersion therapeutic endoscopy.

Capogreco A, Maselli R, Enderle M, Salkic N, Keller S, De Gaetano F, Mastrorocco E, de Sire R, Alfarone L, Massimi D, Jacques J, Legros R, Pioche M, Mori Y, Hassan C, Repici A. Sci Rep. 2025 Feb 5;15(1):4388. doi: 10.1038/s41598-024-83503-3.PMID: 39910260 Free PMC article.

Impact Factor 3.9

Implementation of Artificial Intelligence in Colonoscopy Practice in Japan.

Misawa M, Kudo SE, Mori Y. JMA J. 2025 Jan 15;8(1):60-63. doi: 10.31662/jmaj.2024-0133. Epub 2024 Aug 30.PMID: 39926078 Free PMC article. Review.

Impact Factor 1.8

The Gastroscopy RAte of Cleanliness Evaluation (GRACE) Scale: an international reliability and validation study.

Esposito G, Dilaghi E, Costa-Santos C, Ligato I, Annibale B, Dinis-Ribeiro M, Areia M; GRACE Investigators. Endoscopy. 2025 Apr;57(4):312-320. doi: 10.1055/a-2422-0856. Epub 2024 Sep 25.PMID: 39321961

Level 2 Impact Factor 12.8

Accuracy of Computer-aided Diagnosis in Colonoscopy Varies According to Polyp Location: A Systematic Review and Meta-analysis.

Rizkala T, Hassan C, Mori Y, Spadaccini M, Antonelli G, Dekker E, Houwen BBSL, Pech O, Baumer S, Rondonotti E, Radaelli F, Li JW, von Renteln D, Misawa M, Facciorusso A, Maselli R, Carrara S, Fugazza A, Capogreco A, Khalaf K, Patel H, Sharma P, Rex D, Repici A. Clin Gastroenterol Hepatol. 2025 Mar;23(4):531-541. doi: 10.1016/j.cgh.2024.08.021. Epub 2024 Aug 30.PMID: 39209199

Level 2 Impact Factor 12.2

The role of generative language systems in increasing patient awareness of colon cancer screening.

Maida M, Ramai D, Mori Y, Dinis-Ribeiro M, Facciorusso A, Hassan C; and the AI-CORE (Artificial Intelligence COlorectal cancer Research) Working Group. Endoscopy. 2025 Mar;57(3):262-268. doi: 10.1055/a-2388-6084. Epub 2024 Aug 14.PMID: 39142348 Free article.

Level 2 Impact Factor 12.8

Multicenter analysis of endoscopic full-thickness resection for gastrointestinal lesions in Poland.

Rogalski P, Korcz W, Pilonis ND, Drzewiecki J, Bialek A, Minkiewicz M, Baniukiewicz A, Dabrowski A, Jozwa M, Gietka P, Krolikowski P, Gonciarz M, Jagielski M, Jackowski M, Szlak J, Januszewicz W, Kaminski MF. Scand J Gastroenterol. 2025 Apr;60(4):273-282. doi: 10.1080/00365521.2025.2463950. Epub 2025 Feb 12.PMID: 39937073

Level 1 Impact Factor 1.7

International Validation of a Novel PEACE Scale to Improve the Quality of Upper Gastrointestinal Mucosal Inspection During Endoscopy.

Romańczyk M, Desai M, Kamiński MF, Abe S, Alkandari AA, Beyna T, Bisschops R, Budzyń K, Bugdol M, Grover SC, Gyawali CP, Inoue H, Iyer PG, Messmann H, Ragunath K, Saito Y, Srinivasan S, Teshima C, Yadlapati R, Hassan C, Sharma P. Clin Transl Gastroenterol. 2025 Jan 1;16(1):e00786. doi: 10.14309/ctg.0000000000000786.PMID: 39853720 Free PMC article.

Level 1 Impact Factor 3.0